Trellus Management Company, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.

Quarter-by-quarter ownership
Trellus Management Company, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$559,000
+53.6%
5,0000.0%0.60%
-7.4%
Q1 2020$364,000
+45.6%
5,000
-6.0%
0.65%
+206.6%
Q3 2014$250,000
-39.8%
5,317
-44.6%
0.21%
-59.5%
Q3 2013$415,0009,6000.53%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders